Literature DB >> 22877928

Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis.

Caitlyn D Carpenter1, Taryn O'Neill, Nadia Picot, John A Johnson, Gilles A Robichaud, Duncan Webster, Christopher A Gray.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Common juniper, Juniperus communis, is amongst the plants most frequently used by the indigenous peoples of North America for medicinal purposes. The First Nations of the Canadian Maritimes use infusions of juniper primarily as a tonic and for the treatment of tuberculosis. Previous investigations of extracts derived from the aerial parts of J. communis have shown it to possess anti-mycobacterial activity. The aim of the study is to isolate and identify anti-mycobacterial constituents from the aerial parts of J. communis.
MATERIALS AND METHODS: Methanolic extracts of J. communis needles and branches were subjected to bioassay guided fractionation using the microplate resazurin assay (MRA) to assess inhibitory activity against Mycobacterium tuberculosis strain H37Ra. The anti-mycobacterial constituents were identified by NMR, MS and polarimetry.
RESULTS: The diterpenes isocupressic acid and communic acid and the aryltetralin lignan deoxypodophyllotoxin were isolated from the J. communis extract. Isocupressic acid and communic acid (isolated as an inseparable 3:2 mixture of cis and trans isomers) displayed MICs of 78 μM and 31 μM and IC(50)s of 46 μM and 15 μM against M. tuberculosis H37Ra respectively. Deoxypodophyllotoxin was less active, with a MIC of 1004 μM and an IC(50) of 287 μM.
CONCLUSIONS: Isocupressic acid, communic acid and deoxypodophyllotoxin were identified as the principal constituents responsible for the anti-mycobacterial activity of the aerial parts of J. communis. Although further research will be required to evaluate the relative activities of the two communic acid isomers, this work validates an ethnopharmacological use of this plant by Canadian First Nations and Native American communities.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877928     DOI: 10.1016/j.jep.2012.07.035

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Emergence of HA mutants during influenza virus pneumonia.

Authors:  Maria Eugenia Vázquez Manríquez; Akiko Makino; Motoko Tanaka; Yasuhisa Abe; Hiroyuki Yoshida; Ichiro Morioka; Soichi Arakawa; Yasuhiro Takeshima; Kentaro Iwata; Jin Takasaki; Toshie Manabe; Takaaki Nakaya; Shota Nakamura; Anjarath Lorena Higuera Iglesias; Rosa Maria Rivera Rossales; Erika Pena Mirabal; Tateki Ito; Toshio Kitazawa; Teruaki Oka; Makoto Yamashita; Koichiro Kudo; Kyoko Shinya
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

2.  Antiproliferative Compounds from Cleistanthus boivinianus from the Madagascar Dry Forest.

Authors:  Yixi Liu; Kelly Young; L Harinantenaina Rakotondraibe; Peggy J Brodie; Jessica D Wiley; Maria B Cassera; Martin W Callmander; R Rakotondrajaona; Etienne Rakotobe; Vincent E Rasamison; Karen TenDyke; Yongchun Shen; David G I Kingston
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

3.  Activity of Medicinal Plant Extracts on Multiplication of Mycobacterium tuberculosis under Reduced Oxygen Conditions Using Intracellular and Axenic Assays.

Authors:  Purva D Bhatter; Pooja D Gupta; Tannaz J Birdi
Journal:  Int J Microbiol       Date:  2016-01-31

4.  Potential of Juniperus communis L as a nutraceutical in human and veterinary medicine.

Authors:  Rajinder Raina; Pawan K Verma; Rajinder Peshin; Harpreet Kour
Journal:  Heliyon       Date:  2019-08-31

5.  New Labdanes with Antimicrobial and Acaricidal Activity: Terpenes of Callitris and Widdringtonia (Cupressaceae).

Authors:  Nicholas J Sadgrove; Haytham Senbill; Ben-Erik Van Wyk; Ben W Greatrex
Journal:  Antibiotics (Basel)       Date:  2020-04-11

6.  Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.

Authors:  Nan-Chieh Huang; Ru-Lai Huang; Chih-Yen Hsiao; Shan-Chih Lee; Nu-Man Tsai; Xiao-Fan Huang; Kai-Fu Chang; Chien-Ju Lee
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.